{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:08:31Z","timestamp":1791374911582,"version":"4.3.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007316","name":"division of cancer prevention, national cancer institute","doi-asserted-by":"publisher","award":["1U01CA21002001"],"award-info":[{"award-number":["1U01CA21002001"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00259-021-05595-7","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T04:44:13Z","timestamp":1635914653000},"page":"184-193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Pilot-phase PET\/CT study targeting integrin \u03b1v\u03b26 in pancreatic cancer patients using the cystine-knot peptide\u2013based 18F-FP-R01-MG-F2"],"prefix":"10.1007","volume":"50","author":[{"given":"Ryusuke","family":"Nakamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heying","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Hatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahima","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarrett","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirwais","family":"Wardak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Haywood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowaid","family":"Kellow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0839-5329","authenticated-orcid":false,"given":"Andrei","family":"Iagaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv Sam","family":"Gambhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,3]]},"reference":[{"issue":"3","key":"5595_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA: Cancer J Clin"},{"key":"5595_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA: Cancer J Clin. 2021;71:7\u201333. https:\/\/doi.org\/10.3322\/caac.21654.","journal-title":"CA: Cancer J Clin"},{"key":"5595_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/sla.0000000000001763","volume":"265","author":"PJ Allen","year":"2017","unstructured":"Allen PJ, Kuk D, Castillo CF, Basturk O, Wolfgang CL, Cameron JL, et al. Multi-institutional validation study of the American Joint Commission on Cancer (8th edition) changes for T and N staging in patients with pancreatic adenocarcinoma. Ann Surg. 2017;265:185\u201391. https:\/\/doi.org\/10.1097\/sla.0000000000001763.","journal-title":"Ann Surg."},{"key":"5595_CR4","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1242\/jcs.108.6.2241","volume":"108","author":"J Breuss","year":"1995","unstructured":"Breuss J, Gallo J, DeLisser H, Klimanskaya I, Folkesson H, Pittet J, et al. Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci. 1995;108:2241\u201351.","journal-title":"J Cell Sci"},{"key":"5595_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1365-2559.2004.01919.x","volume":"45","author":"B Sipos","year":"2004","unstructured":"Sipos B, Hahn D, Carceller A, Piulats J, Hedderich J, Kalthoff H, et al. Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro. Histopathology. 2004;45:226\u201336. https:\/\/doi.org\/10.1111\/j.1365-2559.2004.01919.x.","journal-title":"Histopathology"},{"key":"5595_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10735-004-4273-0","volume":"36","author":"S Maubant","year":"2005","unstructured":"Maubant S, Cruet-Hennequart S, Dutoit S, Denoux Y, Crouet H, Henry-Amar M, et al. Expression of alpha V-associated integrin beta subunits in epithelial ovarian cancer and its relation to prognosis in patients treated with platinum-based regimens. J Mol Histol. 2005;36:119\u201329. https:\/\/doi.org\/10.1007\/s10735-004-4273-0.","journal-title":"J Mol Histol"},{"key":"5595_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1600-0560.2007.00810.x","volume":"35","author":"AM Orimoto","year":"2008","unstructured":"Orimoto AM, Neto CF, Pimentel ER, Sanches JA, Sotto MN, Akaishi E, et al. High numbers of human skin cancers express MMP2 and several integrin genes. J Cutan Pathol. 2008;35:285\u201391.","journal-title":"J Cutan Pathol"},{"key":"5595_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1172\/JCI200523183","volume":"115","author":"RC Bates","year":"2005","unstructured":"Bates RC, Bellovin DI, Brown C, Maynard E, Wu B, Kawakatsu H, et al. Transcriptional activation of integrin \u03b26 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Investig. 2005;115:339\u201347.","journal-title":"J Clin Investig"},{"key":"5595_CR9","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.1158\/0008-5472.Can-07-0245","volume":"67","author":"AN Elayadi","year":"2007","unstructured":"Elayadi AN, Samli KN, Prudkin L, Liu YH, Bian A, Xie XJ, et al. A peptide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for nonsmall cell lung cancer. Cancer Res. 2007;67:5889\u201395. https:\/\/doi.org\/10.1158\/0008-5472.Can-07-0245.","journal-title":"Cancer Res"},{"key":"5595_CR10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/path.2168","volume":"212","author":"S Hazelbag","year":"2007","unstructured":"Hazelbag S, Kenter GG, Gorter A, Dreef EJ, Koopman LA, Violette SM, et al. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival. J Pathol. 2007;212:316\u201324. https:\/\/doi.org\/10.1002\/path.2168.","journal-title":"J Pathol"},{"key":"5595_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.clon.2007.09.008","volume":"20","author":"ZY Zhang","year":"2008","unstructured":"Zhang ZY, Xu KS, Wang JS, Yang GY, Wang W, Wang JY, et al. Integrin alphanvbeta6 acts as a prognostic indicator in gastric carcinoma. Clin Oncol (R Coll Radiol). 2008;20:61\u20136. https:\/\/doi.org\/10.1016\/j.clon.2007.09.008.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"5595_CR12","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1038\/s41467-019-11863-w","volume":"10","author":"RH Kimura","year":"2019","unstructured":"Kimura RH, Wang L, Shen B, Huo L, Tummers W, Filipp FV, et al. Evaluation of integrin alphavbeta6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis. Nat Commun. 2019;10:4673. https:\/\/doi.org\/10.1038\/s41467-019-11863-w.","journal-title":"Nat Commun"},{"key":"5595_CR13","first-page":"1023","volume":"46","author":"MG Stabin","year":"2005","unstructured":"Stabin MG, Sparks RB, Crowe E. OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023\u20137.","journal-title":"J Nucl Med"},{"key":"5595_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v043.i05","volume":"43","author":"K Nordhausen","year":"2011","unstructured":"Nordhausen K, Oja H. Multivariate L1 methods: the package MNM. J Stat Softw. 2011;43:1\u201328.","journal-title":"J Stat Softw"},{"key":"5595_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00261-017-1374-2","volume":"43","author":"R Yeh","year":"2018","unstructured":"Yeh R, Dercle L, Garg I, Wang ZJ, Hough DM, Goenka AH. The role of 18F-FDG PET\/CT and PET\/MRI in pancreatic ductal adenocarcinoma. Abdom Radiol (NY). 2018;43:415\u201334. https:\/\/doi.org\/10.1007\/s00261-017-1374-2.","journal-title":"Abdom Radiol (NY)"},{"key":"5595_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.canlet.2017.06.012","volume":"403","author":"J Niu","year":"2017","unstructured":"Niu J, Li Z. The roles of integrin \u03b1v\u03b26 in cancer. Cancer Lett. 2017;403:128\u201337. https:\/\/doi.org\/10.1016\/j.canlet.2017.06.012.","journal-title":"Cancer Lett"},{"key":"5595_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.biocel.2018.04.013","volume":"99","author":"L Koivisto","year":"2018","unstructured":"Koivisto L, Bi J, H\u00e4kkinen L, Larjava H. Integrin \u03b1v\u03b26: structure, function and role in health and disease. Int J Biochem Cell Biol. 2018;99:186\u201396. https:\/\/doi.org\/10.1016\/j.biocel.2018.04.013.","journal-title":"Int J Biochem Cell Biol"},{"key":"5595_CR18","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1021\/acsomega.8b00035","volume":"3","author":"SF F\u00e4rber","year":"2018","unstructured":"F\u00e4rber SF, Wurzer A, Reichart F, Beck R, Kessler H, Wester HJ, et al. Therapeutic radiopharmaceuticals targeting integrin \u03b1v\u03b26. ACS Omega. 2018;3:2428\u201336. https:\/\/doi.org\/10.1021\/acsomega.8b00035.","journal-title":"ACS Omega"},{"key":"5595_CR19","doi-asserted-by":"publisher","first-page":"784","DOI":"10.2967\/jnumed.114.150680","volume":"56","author":"SH Hausner","year":"2015","unstructured":"Hausner SH, Bauer N, Hu LY, Knight LM, Sutcliffe JL. The effect of bi-terminal PEGylation of an integrin \u03b1v\u03b26-targeted 18F peptide on pharmacokinetics and tumor uptake. J Nucl Med. 2015;56:784\u201390. https:\/\/doi.org\/10.2967\/jnumed.114.150680.","journal-title":"J Nucl Med"},{"key":"5595_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.2967\/jnumed.108.058123","volume":"50","author":"EM Nothelfer","year":"2009","unstructured":"Nothelfer EM, Zitzmann-Kolbe S, Garcia-Boy R, Kr\u00e4mer S, Herold-Mende C, Altmann A, et al. Identification and characterization of a peptide with affinity to head and neck cancer. J Nucl Med. 2009;50:426\u201334. https:\/\/doi.org\/10.2967\/jnumed.108.058123.","journal-title":"J Nucl Med"},{"key":"5595_CR21","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1074\/jbc.274.4.1979","volume":"274","author":"S Kraft","year":"1999","unstructured":"Kraft S, Diefenbach B, Mehta R, Jonczyk A, Luckenbach GA, Goodman SL. Definition of an unexpected ligand recognition motif for alphav beta6 integrin. J Biol Chem. 1999;274:1979\u201385. https:\/\/doi.org\/10.1074\/jbc.274.4.1979.","journal-title":"J Biol Chem"},{"key":"5595_CR22","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1158\/1078-0432.CCR-16-3217","volume":"23","author":"A Altmann","year":"2017","unstructured":"Altmann A, Sauter M, Roesch S, Mier W, Warta R, Debus J, et al. Identification of a novel ITGalphavbeta6-binding peptide using protein separation and phage display. Clin Cancer Res. 2017;23:4170\u201380. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-3217.","journal-title":"Clin Cancer Res"},{"key":"5595_CR23","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s11307-018-1296-6","volume":"21","author":"P Flechsig","year":"2019","unstructured":"Flechsig P, Lindner T, Loktev A, Roesch S, Mier W, Sauter M, et al. PET\/CT Imaging of NSCLC with a alphavbeta6 integrin-targeting peptide. Mol Imaging Biol. 2019;21:973\u201383. https:\/\/doi.org\/10.1007\/s11307-018-1296-6.","journal-title":"Mol Imaging Biol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-021-05595-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-021-05595-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-021-05595-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T12:04:11Z","timestamp":1668600251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-021-05595-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,3]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["5595"],"URL":"https:\/\/doi.org\/10.1007\/s00259-021-05595-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,3]]},"assertion":[{"value":"25 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Yes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Yes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}